Parallel Advisors’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $224K | Sell |
2,214
-158
| -7% | -$16.4K | ﹤0.01% | 1202 |
|
|
2026
Q1 | $229K | Sell |
2,372
-481
| -17% | -$49.3K | ﹤0.01% | 1101 |
|
|
2025
Q4 | $303K | Sell |
2,853
-282
| -9% | -$32.7K | 0.01% | 904 |
|
|
2025
Q3 | $398K | Buy |
3,135
+532
| +20% | +$63.3K | 0.01% | 755 |
|
|
2025
Q2 | $319K | Buy |
2,603
+284
| +12% | +$32.4K | 0.01% | 801 |
|
|
2025
Q1 | $235K | Buy |
2,319
+464
| +25% | +$45.3K | 0.01% | 890 |
|
|
2024
Q4 | $171K | Buy |
1,855
+144
| +8% | +$14.1K | ﹤0.01% | 1002 |
|
|
2024
Q3 | $165K | Buy |
1,711
+495
| +41% | +$44.5K | ﹤0.01% | 1012 |
|
|
2024
Q2 | $104K | Buy |
1,216
+332
| +38% | +$27.9K | ﹤0.01% | 1166 |
|
|
2024
Q1 | $73K | Buy |
884
+311
| +54% | +$22.8K | ﹤0.01% | 1316 |
|
|
2023
Q4 | $38.2K | Buy |
573
+377
| +192% | +$24.4K | ﹤0.01% | 1572 |
|
|
2023
Q3 | $13.2K | Buy |
196
+37
| +23% | +$2.54K | ﹤0.01% | 2072 |
|
|
2023
Q2 | $10.8K | Hold |
159
| – | – | ﹤0.01% | 2142 |
|
|
2023
Q1 | $8.6K | Buy |
159
+20
| +14% | +$1.16K | ﹤0.01% | 2197 |
|
|
2022
Q4 | $8.31K | Sell |
139
-6
| -4% | -$326 | ﹤0.01% | 2102 |
|
|
2022
Q3 | $7K | Buy |
145
+19
| +15% | +$951 | ﹤0.01% | 2141 |
|
|
2022
Q2 | $6K | Sell |
126
-325
| -72% | -$16.7K | ﹤0.01% | 2168 |
|
|
2022
Q1 | $26K | Sell |
451
-218
| -33% | -$11.4K | ﹤0.01% | 1591 |
|
|
2021
Q4 | $35K | Buy |
669
+504
| +305% | +$26K | ﹤0.01% | 1523 |
|
|
2021
Q3 | $10K | Hold |
165
| – | – | ﹤0.01% | 2057 |
|
|
2021
Q2 | $10K | Hold |
165
| – | – | ﹤0.01% | 1991 |
|
|
2021
Q1 | $11K | Buy |
165
+15
| +10% | +$978 | ﹤0.01% | 1870 |
|
|
2020
Q4 | $10K | Sell |
150
-106
| -41% | -$6.24K | ﹤0.01% | 1777 |
|
|
2020
Q3 | $13K | Sell |
256
-4
| -2% | -$205 | ﹤0.01% | 1616 |
|
|
2020
Q2 | $12K | Buy |
260
+112
| +76% | +$6.04K | ﹤0.01% | 1635 |
|
|
2020
Q1 | $7K | Sell |
148
-108
| -42% | -$6.23K | ﹤0.01% | 1770 |
|
|
2019
Q4 | $14K | Hold |
256
| – | – | ﹤0.01% | 1573 |
|
|
2019
Q3 | $13K | Sell |
256
-114
| -31% | -$5.73K | ﹤0.01% | 1559 |
|
|
2019
Q2 | $19K | Hold |
370
| – | – | ﹤0.01% | 1303 |
|
|
2019
Q1 | $17K | Hold |
370
| – | – | ﹤0.01% | 1287 |
|
|
2018
Q4 | $18K | Sell |
370
-30
| -8% | -$1.71K | ﹤0.01% | 1090 |
|
|
2018
Q3 | $25K | Buy |
400
+186
| +87% | +$11.3K | ﹤0.01% | 1057 |
|
|
2018
Q2 | $11K | Buy |
214
+30
| +16% | +$1.5K | ﹤0.01% | 1297 |
|
|
2018
Q1 | $8K | Hold |
184
| – | – | ﹤0.01% | 1356 |
|
|
2017
Q4 | $7K | Buy |
184
+43
| +30% | +$1.64K | ﹤0.01% | 1424 |
|
|
2017
Q3 | $5K | Sell |
141
-5
| -3% | -$178 | ﹤0.01% | 1572 |
|
|
2017
Q2 | $5K | Buy |
146
+5
| +4% | +$183 | ﹤0.01% | 1586 |
|
|
2017
Q1 | $5K | Sell |
141
-19
| -12% | -$624 | ﹤0.01% | 1481 |
|
|
2016
Q4 | $5K | Buy |
+160
| New | +$5.19K | ﹤0.01% | 1353 |
|
Other funds holding EHC
CCM
RP
CAM
TCM
Parallel Advisors's EHC Position: Q2 2026 in Review
Parallel Advisors reduced its Encompass Health (EHC) stake by 6.7% in Q2 2026, selling an estimated $16.4K and leaving 2,214 shares worth $224K. The position accounts for ﹤0.01% of the portfolio, ranked #1202.
Parallel Advisors first reported a position in EHC in Q4 2016 and has held it in 39 quarters since. The position peaked at $398K in Q3 2025. 274 funds tracked by Wall St. Rank hold EHC as of Q2 2026.
- Parallel Advisors held 2,214 shares of Encompass Health worth $224K as of Q2 2026.
- Parallel Advisors sold 158 Encompass Health shares in Q2 2026, an estimated $16.4K.
- Encompass Health made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #1202 holding.
- Parallel Advisors first reported a position in Encompass Health in Q4 2016 and has held it in 39 quarters since.
- Parallel Advisors's Encompass Health position peaked at $398K in Q3 2025.
- 274 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.
Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.